MBX Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2023 | $4.3M | $84.2M | $30.5M |
| Sep 2024 | $11.0M | $282.4M | $132.9M |
| Dec 2024 | $11.1M | $268.5M | $49.4M |
| Mar 2025 | $10.5M | $245.9M | $29.9M |
| Jun 2025 | $12.3M | $231.5M | $39.8M |
| Sep 2025 | $12.5M | $400.1M | $223.1M |
| Dec 2025 | $15.9M | $385.1M | $75.3M |
| Mar 2026 | $14.9M | $452.7M | $45.2M |
| Jun 2026 | $26.4M | $435.9M | $54.1M |